SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ahmed Al-Qahtani, Mashael Al-Anazi, Ayman A. Abdo, Faisal M. Sanai, Waleed Al-Hamoudi, Khalid A. Alswat, Hamad I. Al-Ashgar, Mohammed Q. Khan, Ali Albenmousa, Nisreen Khalaf, Nisha Viswan, Mohammed N. Al-Ahdal, Correlation between Genetic Variations and Serum Level of Interleukin 28B with Virus Genotypes and Disease Progression in Chronic Hepatitis C Virus Infection, Journal of Immunology Research, 2015, 2015, 1

    CrossRef

  2. 2
    Savino Bruno, Alex J. Thompson, Rosina Critelli, Andrea Crosignani, Sonia Rossi, Stefania De Lisi, Elisabetta Cariani, Paola Zermiani, Valentina Vaira, Vincenzo Boccaccio, Patrick Maisonneuve, Erica Villa, Interferon lambda-3 is not associated with clinical outcome in patients with HCV-induced compensated cirrhosis: A long-term cohort study, Antiviral Research, 2015, 113, 27

    CrossRef

  3. 3
    Mohammed Eslam, Ahmed M. Hashem, Reynold Leung, Manuel Romero-Gomez, Thomas Berg, Gregory J. Dore, Henry L.K. Chan, William L. Irving, David Sheridan, Maria L. Abate, Leon A. Adams, Alessandra Mangia, Martin Weltman, Elisabetta Bugianesi, Ulrich Spengler, Olfat Shaker, Janett Fischer, Lindsay Mollison, Wendy Cheng, Elizabeth Powell, Jacob Nattermann, Stephen Riordan, Duncan McLeod, Nicola J. Armstrong, Mark W. Douglas, Christopher Liddle, David R. Booth, Jacob George, Golo Ahlenstiel, Javier Ampuero, Margaret Bassendine, Vincent W. S. Wong, Chiara Rosso, Rose White, Lavinia Mezzabotta, Vijayaprakash Suppiah, Monika Michalk, Barbara Malik, Gail Matthews, Tanya Applegate, Jason Grebely, Vincenzo Fragomeli, Julie R. Jonsson, Rosanna Santaro, Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease, Nature Communications, 2015, 6, 6422

    CrossRef

  4. 4
    Leonardo Mottola, Giovanni Cenderello, Valeria A. Piazzolla, Paolo Forte, Vito Carretta, Fabrizio Mecenate, Giuseppina Brancaccio, Rosalba Minisini, Massimo Zuin, Natalia Terreni, Monica Monti, Alberto Eraldo Colombo, Lorenzo Nosotti, Nicola Minerva, Ilaria Luzzitelli, Alba Kostandini, Giuseppe Cuccorese, Maurizio Russello, Rosanna Santoro, Alessandra Mangia, Interleukin-28B genetic variants in untreated Italian HCV-infected patients: a multicentre study, Liver International, 2015, 35, 2
  5. 5
    Normeen Hany Rady, Rania Kamal Darwish, Engy Adel Mogahed, Iman Atef Mandour, Hazem Abo Youssef, Sahar Abdel Atty Sharaf, Hanaa Mostafa El-Karaksy, Potential genetic markers for prediction of treatment response in Egyptian children infected with HCV genotype 4, Cytokine, 2015,

    CrossRef

  6. 6
    Mattias Mandorfer, Berit A. Payer, Philipp Schwabl, Sebastian Steiner, Arnulf Ferlitsch, Maximilian C. Aichelburg, Albert F. Stättermayer, Peter Ferenci, Barbara Obermayer-Pietsch, Katharina Grabmeier-Pfistershammer, Michael Trauner, Markus Peck-Radosavljevic, Thomas Reiberger, Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3, Liver International, 2015, 35, 3
  7. 7
    Luis M. Real, Antonio Caruz, Antonio Rivero-Juarez, Vicente Soriano, Karin Neukam, Antonio Rivero, Celia Cifuentes, José A. Mira, Juan Macías, Juan A. Pineda, A polymorphism linked to RRAS,SCAF1,IRF3 and BCL2L12 genes is associated with cirrhosis in hepatitis C virus carriers, Liver International, 2014, 34, 4
  8. 8
    Samar Samir Youssef, Eman Abd El-Razek Abbas, Asmaa Mostafa Abd el Aal, Taher el Zanaty, Sameh Mohamed Seif, Association ofIL28BPolymorphism with Fibrosis, Liver Inflammation, Gender Respective Natural History of Hepatitis C Virus in Egyptian Patients with Genotype 4, Journal of Interferon & Cytokine Research, 2014, 34, 1, 22

    CrossRef

  9. 9
    Ahmed A. Al-Qahtani, Mashael R. Al-Anazi, Ayman A. Abdo, Faisal M. Sanai, Waleed K. Al-Hamoudi, Khalid A. Alswat, Hamad I. Al-Ashgar, Nisreen Z. Khalaf, Nisha A. Viswan, Mohammed N. Al Ahdal, Genetic variation in interleukin 28B and correlation with chronic hepatitis B virus infection in Saudi Arabian patients, Liver International, 2014, 34, 7
  10. 10
    Yasuhiro Asahina, Kaoru Tsuchiya, Takashi Nishimura, Masaru Muraoka, Yuichiro Suzuki, Nobuharu Tamaki, Yutaka Yasui, Takanori Hosokawa, Ken Ueda, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Masayuki Kurosaki, Nobuyuki Enomoto, Mina Nakagawa, Sei Kakinuma, Mamoru Watanabe, Namiki Izumi, Genetic variation near interleukin 28B and the risk of hepatocellular carcinoma in patients with chronic hepatitis C, Journal of Gastroenterology, 2014, 49, 7, 1152

    CrossRef

  11. 11
    K S O'Connor, G Parnell, E Patrick, G Ahlenstiel, V Suppiah, D van der Poorten, S A Read, R Leung, M W Douglas, J YH Yang, G J Stewart, C Liddle, J George, D R Booth, Hepatic metallothionein expression in chronic hepatitis C virus infection is IFNL3 genotype-dependent, Genes and Immunity, 2014, 15, 2, 88

    CrossRef

  12. 12
    Q. Zhang, M. Lapalus, T. Asselah, C. Laouénan, R. Moucari, M. Martinot-Peignoux, I. Bieche, E. Estrabaud, S. De Muynck, N. Boyer, P. Bedossa, M. Vidaud, P. Marcellin, O. Lada, IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patients, Journal of Viral Hepatitis, 2014, 21, 7
  13. 13
    Masaya Sato, Naoya Kato, Ryosuke Tateishi, Ryosuke Muroyama, Norie Kowatari, Wenwen Li, Kaku Goto, Motoyuki Otsuka, Shuichiro Shiina, Haruhiko Yoshida, Masao Omata, Kazuhiko Koike, IL28B minor allele is associated with a younger age of onset of hepatocellular carcinoma in patients with chronic hepatitis C virus infection, Journal of Gastroenterology, 2014, 49, 4, 748

    CrossRef

  14. 14
    M. A. Jiménez-Sousa, J. Berenguer, A. Fernández-Rodríguez, D. Micheloud, M. Guzmán-Fulgencio, P. Miralles, D. Pineda-Tenor, M. García–Álvarez, J. C. López, T. Aldámiz-Echevarria, A. Carrero, S. Resino, IL28RA polymorphism (rs10903035) is associated with insulin resistance in HIV/HCV-coinfected patients, Journal of Viral Hepatitis, 2014, 21, 3
  15. 15
    Matthew T Kitson, Jacob George, Gregory J Dore, Reynold Leung, Peter Button, Geoffrey W McCaughan, Darrell H G Crawford, William Sievert, Martin D Weltman, Wendy S C Cheng, Stuart K Roberts, Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infection, Journal of Gastroenterology and Hepatology, 2014, 29, 7
  16. 16
    Nicolas Goossens, Francesco Negro, Is genotype 3 of the hepatitis C virus the new villain?, Hepatology, 2014, 59, 6
  17. 17
    Nikolaus Jilg, Wenyu Lin, Jian Hong, Esperance A. Schaefer, David Wolski, James Meixong, Kaku Goto, Cynthia Brisac, Pattranuch Chusri, Dahlene N. Fusco, Stephane Chevaliez, Jay Luther, Kattareeya Kumthip, Thomas J. Urban, Lee F. Peng, Georg M. Lauer, Raymond T. Chung, Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus, Hepatology, 2014, 59, 4
  18. 18
    Knut Boe Kielland, Gerd Jorunn Møller Delaveris, Sidsel Rogde, Tor Jacob Eide, Ellen J. Amundsen, Olav Dalgard, Liver fibrosis progression at autopsy in injecting drug users infected by hepatitis C: A longitudinal long-term cohort study, Journal of Hepatology, 2014, 60, 2, 260

    CrossRef

  19. 19
    Youngmin A. Lee, Scott L. Friedman, Reversal, maintenance or progression: What happens to the liver after a virologic cure of hepatitis C?, Antiviral Research, 2014, 107, 23

    CrossRef

  20. 20
    Kentaro Matsuura, Tsunamasa Watanabe, Yasuhito Tanaka, Role of IL28B for chronic hepatitis C treatment toward personalized medicine, Journal of Gastroenterology and Hepatology, 2014, 29, 2
  21. 21
    Simone Regina Souza da Silva Conde, Julius Caesar Mendes Soares Monteiro, Bruna Tereza Silva dos Santos, Nathália Karla Fonseca Filgueiras, Pedro Alves de Almeida Lins, Felipe Bonfim Freitas, Ednelza da Silva Graça, Sâmia Demachki, Marialva Tereza Ferreira de Araújo, Ricardo Ishak, Antonio Carlos Rosário Vallinoto, SNP rs8099917 in Gene IL28B Might Be Associated with Risk of Chronic Infection by HCV but Not with Response to Treatment, BioMed Research International, 2014, 2014, 1

    CrossRef

  22. 22
    L. Covolo, S. Bibert, F. Donato, P.-Y. Bochud, M. Lagging, F. Negro, G. Fattovich, The novel ss469415590 variant predicts virological response to therapy in patients with chronic hepatitis C virus type 1 infection, Alimentary Pharmacology & Therapeutics, 2014, 39, 3
  23. 23
    C. Bucci, A. von Delft, A. Christian, V. M. Flemming, A. Harrison, J. Halliday, J. Collier, C. Manganis, P. Klenerman, W. Irving, E. Barnes, 'Favourable' IL28B polymorphisms are associated with a marked increase in baseline viral load in hepatitis C virus subtype 3a infection and do not predict a sustained virological response after 24 weeks of therapy, Journal of General Virology, 2013, 94, Pt_6, 1259

    CrossRef

  24. 24
    Mazen Noureddin, Elizabeth C. Wright, Harvey J. Alter, Shauna Clark, Emmanuel Thomas, Richard Chen, Xiongce Zhao, Cathy Conry-Cantilena, David E. Kleiner, T. Jake Liang, Marc G. Ghany, Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: A longitudinal analysis, Hepatology, 2013, 58, 5
  25. 25
    Rajagopal N. Aravalli, Erik N. K. Cressman, Clifford J. Steer, Cellular and molecular mechanisms of hepatocellular carcinoma: an update, Archives of Toxicology, 2013, 87, 2, 227

    CrossRef

  26. 26
    Scott W. Biggins, James Trotter, Jane Gralla, James R. Burton, Kiran M. Bambha, Jennifer Dodge, Megan Brocato, Linling Cheng, Matt McQueen, Lisa Forman, Michael Chang, Igal Kam, Gregory Everson, Richard A. Spritz, Goran Klintmalm, Hugo R. Rosen, Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation, Journal of Hepatology, 2013, 58, 5, 969

    CrossRef

  27. 27
    Salvatore Petta, Chiara Rosso, Reynold Leung, Maria Lorena Abate, David Booth, Federico Salomone, Roberto Gambino, Mario Rizzetto, Paolo Caviglia, Antonina Smedile, Stefania Grimaudo, Calogero Cammà, Antonio Craxì, Jacob George, Elisabetta Bugianesi, Effects of IL28B rs12979860 CC Genotype on Metabolic Profile and Sustained Virologic Response in Patients With Genotype 1 Chronic Hepatitis C, Clinical Gastroenterology and Hepatology, 2013, 11, 3, 311

    CrossRef

  28. 28
    Chen-Hua Liu, Jia-Horng Kao, IL28B Genotype on HCV Infection in Asia, Current Hepatitis Reports, 2013, 12, 3, 149

    CrossRef

  29. 29
    María Guzmán-Fulgencio, Juan Berenguer, Mónica García-Álvarez, Amanda Fernández-Rodríguez, María A. Jiménez-Sousa, Emilio Álvarez, Dariela Micheloud, Juan Carlos López, Pilar Miralles, Jaime Cosín, Pilar Catalán, Salvador Resino, IL28B polymorphisms are associated with severity of liver disease in human immunodeficiency virus (HIV) patients coinfected with hepatitis C virus, Journal of Infection, 2013, 66, 2, 170

    CrossRef

  30. 30
    Concha de la Fuente, Carmen Hinojosa, Isabel Gilabert, Maria Ángeles Jiménez Sousa, Jose Manuel González, Raúl Ortiz de Lejarazu, Ana Loma, Concepción Nieto, Rosa Arnaiz, Jesús F. Bermejo-Martin, Interleukin 28B rs12979860 (CT/TT) Genotype Is Associated with Milder Hepatic Damage in the Natural Evolution of HCV/HIV Coinfection, Journal of Interferon & Cytokine Research, 2013, 33, 1, 43

    CrossRef

  31. 31
    Adriaan J. Meer, Raoel Maan, Robert J. Knegt, Bart J. Veldt, Natural History of HCV-induced Liver Disease, Current Hepatitis Reports, 2013, 12, 4, 251

    CrossRef

  32. 32
    Amanda Fernández-Rodríguez, Juan Berenguer, María A. Jiménez-Sousa, María Guzmán-Fulgencio, Dariela Micheloud, Pilar Miralles, Juan Carlos López, José María Bellón, Teresa Aldamiz-Echevarria, Pilar García–Broncano, Ana Carrero, Emilio Álvarez, Salvador Resino, Prediction of Hepatic Fibrosis in Patients Coinfected With HIV and Hepatitis C Virus Based on Genetic Markers, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2013, 64, 5, 434

    CrossRef

  33. 33
    Martin Lagging, Karolina Rembeck, Mads Rauning Buhl, Peer Christensen, Olav Dalgard, Martti Färkkilä, Kristoffer Hellstrand, Nina Langeland, Magnus Lindh, Johan Westin, Gunnar Norkrans, Retreatment with peg-interferon and ribavirin in patients with chronic hepatitis C virus genotype 2 or 3 infection with prior relapse, Scandinavian Journal of Gastroenterology, 2013, 48, 7, 839

    CrossRef

  34. 34
    Jacinta A. Holmes, Alexander J. Thompson, Leon A. Adams, Biomarkers of Fibrosis and Fibrosis Progression in Chronic Hepatitis C, Current Hepatitis Reports, 2012, 11, 4, 231

    CrossRef

  35. 35
    Norio Akuta, Fumitaka Suzuki, Yuya Seko, Yusuke Kawamura, Hitomi Sezaki, Yoshiyuki Suzuki, Tetsuya Hosaka, Masahiro Kobayashi, Tasuku Hara, Mariko Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Hiromitsu Kumada, Complicated relationships of amino acid substitution in hepatitis C virus core region and IL28B genotype influencing hepatocarcinogenesis, Hepatology, 2012, 56, 6
  36. 36
    Etienne Patin, Zoltán Kutalik, Julien Guergnon, Stéphanie Bibert, Bertrand Nalpas, Emmanuelle Jouanguy, Mona Munteanu, Laurence Bousquet, Laurent Argiro, Philippe Halfon, Anne Boland, Beat Müllhaupt, David Semela, Jean–François Dufour, Markus H. Heim, Darius Moradpour, Andreas Cerny, Raffaele Malinverni, Hans Hirsch, Gladys Martinetti, Vijayaprakash Suppiah, Graeme Stewart, David R. Booth, Jacob George, Jean–Laurent Casanova, Christian Bréchot, Charles M. Rice, Andrew H. Talal, Ira M. Jacobson, Marc Bourlière, Ioannis Theodorou, Thierry Poynard, Francesco Negro, Stanislas Pol, Pierre–Yves Bochud, Laurent Abel, Genome-Wide Association Study Identifies Variants Associated With Progression of Liver Fibrosis From HCV Infection, Gastroenterology, 2012, 143, 5, 1244

    CrossRef

  37. 37
    Emilie Estrabaud, Michel Vidaud, Patrick Marcellin, Tarik Asselah, Genomics and HCV infection: Progression of fibrosis and treatment response, Journal of Hepatology, 2012, 57, 5, 1110

    CrossRef

  38. 38
    Monika Rau, Katharina Baur, Andreas Geier, Host Genetic Variants in the Pathogenesis of Hepatitis C, Viruses, 2012, 4, 12, 3281

    CrossRef

  39. 39
    Donald M. Jensen, Stanislas Pol, IL28B genetic polymorphism testing in the era of direct acting antivirals therapy for chronic hepatitis C: ten years too late?, Liver International, 2012, 32,
  40. 40
    Martin Lagging, Impact ofIL28BSNPs on therapeutic outcome and liver histology differs between hepatitis C virus genotypes, Pharmacogenomics, 2012, 13, 8, 847

    CrossRef

  41. 41
    L. Valenti, A. Aghemo, A. F. Stättermayer, P. Maggioni, S. Nicola, B. M. Motta, M. G. Rumi, P. Dongiovanni, P. Ferenci, M. Colombo, S. Fargion, Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin, Alimentary Pharmacology & Therapeutics, 2012, 35, 12
  42. 42
    Makiko Takeyasu, Norio Akuta, Fumitaka Suzuki, Yuya Seko, Yusuke Kawamura, Hitomi Sezaki, Yoshiyuki Suzuki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Yasuji Arase, Kenji Ikeda, Hiromitsu Kumada, Long-term interferon monotherapy reduces the risk of HCV-associated hepatocellular carcinoma, Journal of Medical Virology, 2012, 84, 8
  43. 43
    Tatsuo Miyamura, Tatsuo Kanda, Shingo Nakamoto, Shuang Wu, Xia Jiang, Makoto Arai, Keiichi Fujiwara, Fumio Imazeki, Osamu Yokosuka, Roles of ITPA and IL28B Genotypes in Chronic Hepatitis C Patients Treated with Peginterferon Plus Ribavirin, Viruses, 2012, 4, 12, 1264

    CrossRef

  44. 44
    F. Bellanti, G. Vendemiale, E. Altomare, G. Serviddio, The Impact of Interferon Lambda 3 Gene Polymorphism on Natural Course and Treatment of Hepatitis C, Clinical and Developmental Immunology, 2012, 2012, 1

    CrossRef

  45. 45
    Martin Lagging, Ann-Sofi Duberg, Rune Wejstål, Ola Weiland, Magnus Lindh, Soo Aleman, Filip Josephson, Treatment of hepatitis C virus infection in adults and children: Updated Swedish consensus recommendations, Scandinavian Journal of Infectious Diseases, 2012, 44, 7, 502

    CrossRef

  46. 46
    Nicholas A Shackel, When has the horse bolted?, Journal of Gastroenterology and Hepatology, 2012, 27, 7